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Prevention and control measures
Bernard Bett, Ram Deka, V Padmakumar and M Rajasekhar
What is classical swine fever? And why 
does it matter?
 
Classical swine fever (CSF) is a highly contagious, po-
tentially fatal viral disease that affects pigs. This disease 
is a major constraint to the development of pig farming 
systems in northeast India where pig farming is a main 
source of livelihood for most households. About 80% of 
households in northeast India rear pigs and pork is a key 
part of the local diet. 
Impact of CSF on local economies  
and livelihoods
 
A 2011 participatory epidemiological study conducted in 
Assam, Nagaland and Mizoram by the International Livestock 
Research Institute (ILRI) with support from the Sir Ratan Tata 
Trust (SRTT) and Navajbai Ratan Tata Trust (NRTT) showed 
that pig farmers in India incur huge losses from mortality, 
treatment and replacement costs—over 2 billion Indian ru-
pees (INR) each year (INR 57.0437 = USD 1 at 28 June 2012) 
(see Table 1). 
Table 1. Projected economic loss from CSF in three northeast Indian states (in million INR) 
 
Assam Mizoram Nagaland Total
Cost of mortality 1775.74 33.98 267.25 2076.97
Cost of treatment 24.07 0.44 0.004 24.51
Cost of replacement 102.10 1.93 18.79 122.82
Total costs 1901.91 36.35 286.04 2224.30
Source: PE study, ILRI (2011).
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CSF control options 
Recommended measures to control CSF include the use of 
sanitary prophylaxis (disease reporting, strict import policy, 
quarantine, routine serological surveillance) and medical pro-
phylaxis (use of a modified live-virus vaccine). India requires 
a total of 22.26 million doses of CSF vaccine per year, with 
northeast India alone requiring 7.64 million doses. 
Currently, the country has about 1.2 million doses of the vac-
cine, which is less than 1% of the total requirement (Table 2 
below).
 
Table 2. Vaccine availability and requirement  
India
Northeast 
India
Number of pigs 11.13 million 3.82 million
Vaccination  
doses required/year
22.26 million 7.64 million
Vaccine availability 
1.2 million doses1  
(lapinized CSF 
vaccine)
0.04 million
Gap 21.06 million doses/year
7.60 million  
doses/year
Source: D.K. Sharma, ICAR (2011). 
1. About 3 lakh doses by IVRI, 1 lakh doses by Institute of AH&V Biologicals, 
Mhow, 19000 doses by Veterinary Biological Institute, Guwahati and the 
remaining by other institutes (details not available). Reference year 2010.
Three vaccine types are available in India 
Lapinized vaccine: is developed by serial passage of CSF 
virus in rabbits, and the vaccine is processed from the 
spleen and other lymphoid tissues of the infected rabbits. 
The biggest limitation in the production of this vaccine is 
its dependence on the availability and continuous supply of 
rabbits. 
This vaccine is currently produced by the Institute of 
Veterinary Biologicals at Guwahati, Kolkata, Lucknow, the 
Institute of Animal Health and Veterinary Biologicals, Mhow 
and Indian Veterinary Research Institute, Izatnagar.
Lapinized cell culture vaccine: The lapinized vaccine strain 
is used to produce vaccine in cell culture. Production of 
this vaccine does not depend on availability of rabbits and 
can therefore be made in large quantities. This vaccine is 
currently produced on ‘trial basis’ by the Institute of Animal 
Health and Veterinary Biologicals (IAHVB) in Bangalore. 
Its commercial production is expected soon after licensing 
is received from government. It is reported that the Indian 
Veterinary Research Institute also has developed this tech-
nology and is working towards its commercial production. 
Production and use of this vaccine appears to be the best 
available choice. 
The available infrastructure in some of the veterinary 
biological institutes can be used for this purpose but with 
additional equipment and capacity strengthening.
Cell culture vaccine: Local CSF virus is isolated from the 
field during disease outbreak and grown in cell culture 
and attenuated to produce the vaccine. This technology 
(developed by Dilip Kamur Sharma of Assam Agricultural 
University) is in the experimental stage. 
Though this vaccine is of immense value in the imple-
mentation of northeast India’s regional and national 
CSF control and eradication programs, its commercial 
production will take time.
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Policy recommendation for prevention 
and control of CSF
•	 To meet the immediate demand, the lapinized vaccine 
production facilities at the Institute of Veterinary Biologi-
cals (Guwahati, Kolkata, Lucknow) and at the Institute of 
Animal Health and Veterinary Biologicals, Mhow, should be 
strengthened with infrastructure and manpower support. 
This can increase production level from the current 
1.2 million doses to 5 million doses within one year.
•	 Simultaneously, to meet the country’s entire demand, 
commercialization of the lapinized cell culture vaccine 
technology through public–private partnership is a next 
best option. In this context, the plan by the Indian 
Veterinary Research Institute to commercialize this 
technology through private firms may be strongly 
supported. 
•	 In the long run, the cell culture CSF vaccine should 
replace the lapinized cell culture vaccine and pro-
duction of the latter stopped. To produce this vaccine 
on a commercial basis, the seed virus strain available 
at Assam Agricultural University (AAU) should be made 
available to vaccine manufacturers on terms and 
conditions specified by AAU after its independent 
validation.
•	 There is a need to strengthen the ‘cold chain facilities’ at 
the Institute of Veterinary Biologicals, Guwahati and the 
vaccine storage capacity at the headquarters of each state 
in the region. Also, portable mini cold storage facilities 
and transport boxes (similar to those provided under 
the Government’s rinderpest eradication program) 
should be made available to all veterinary institutions 
to enable preservation and distribution of vaccines to 
sparsely distributed livestock populations. 
•	 Given the limited human resource capacity in state 
government departments, a system of delivery of 
vaccination services (including awareness creation) by 
trained ‘vaccination scouts’ can be established under the 
supervision of the animal husbandry and veterinary 
departments.
•	 Strengthening of laboratory infrastructure for rapid CSF 
diagnosis and initiation of disease control measures 
by the state veterinary authorities.
•	 After bringing down the disease to a considerable 
level, in the long term, develop a strategy for vaccina-
tion at key border points/markets/trade routes and 
develop quarantine facilities.
•	 Movement of pigs from outside the northeast region 
and from neighbouring countries should be moni-
tored.
•	 State CSF surveillance units should be set up in each 
states directorate of Animal Husbandry and Veteri-
nary Services and the state epidemiologist with his/
her colleagues should independently investigate all 
disease outbreaks supported by laboratory investi-
gations. These surveillance units need to have labo-
ratory diagnostics (from Assam Agricultural Univer-
sity AAU), adequate staff and computers, internet 
and other inputs. A mobile disease investigation 
vehicle fitted with basic diagnostic laboratory equip-
ments may also be placed at the disposal of field 
disease investigation teams along with other special-
ist diagnosticians. Online management information 
systems should capture information on vaccination, 
vaccinators, blood samples etc.
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•	 National CSF control/eradication policy–program: The 
government my consider launching a national CSF 
control/eradication program with particular focus 
on northeast India under the ensuing 12th plan 
period. This may be designed similar to the rinder-
pest eradication program and unused infrastructure 
and human resources from the rinderpest program 
could be utilized in the new program.
•	 A new regional vaccine production centre exclusively for 
CSF may be established at Guwahati. A committee may 
be formed to prepare a detailed project report for the 
establishment of the centre. 
This brief has been prepared by ILRI’s Enhancing livelihoods through livestock knowledge systems team, drawing content from the participatory epide-
miological study by Bernard Bett (ILRI) and another ILRI study on the status of vaccine production and delivery by M Rajasekhar (consultant) under the 
TATA–ILRI partnership program.
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